Hormone Replacement Therapy and Peripheral Arterial Disease
نویسندگان
چکیده
منابع مشابه
Hormone replacement therapy and cardiovascular disease.
Oestrogen alone probably confers a degree of protection against ischaemic heart disease and stroke and is appropriate for women requiring hormone replacement therapy (HRT) who have undergone hysterectomy. However, the cardiovascular effects of the progestogens used with oestrogen in the much larger number of women who have not undergone hysterectomy are unknown. Some widely used progestogens ha...
متن کاملHormone replacement therapy and coronary heart disease.
Proper use of postmenopausal hormone replacement has been the subject of debate for decades. Prevailing medical opinion has swung between enthusiastic endorsement and extreme caution. The wave of optimism over estrogen's beneficial effects on menopausal symptoms and skeletal health was temporarily set back by the evidence that linked estrogen to endometrial cancer. Once studies showed that prog...
متن کاملPostmenopausal hormone replacement therapy and cardiovascular disease.
Cardiovascular disease is the leading cause of mortality in postmenopausal women in developed countries. A possible cardioprotective role of hormone replacement therapy (HRT) is suggested by epidemiologic studies of HRT and reduced risk of coronary heart disease, as well as by randomized trials of HRT and lipid subfractions. Estrogen has beneficial effects on the lipid profile, raising high-den...
متن کاملHormone replacement therapy and Alzheimer's disease.
There is ample evidence to show the beneficial effect of estrogen on the risk and course of Alzheimer's disease (AD). Estrogen may play a role in the pathophysiology of AD through improvement of cerebral blood flow, stimulation of the neuron or gliacyte and interaction with genetic factors. Most etiological studies of estrogen replacement therapy and AD have been retrospective studies. In these...
متن کامل[Cardiovascular disease and hormone replacement therapy].
In Canada, cardiovascular disease (CVD) is the leading cause of mortality. In 1990, CVD killed 36,266 Canadian women. This represents 41 percent of deaths in women and is greater than all deaths due to cancer.' On average, Canadian women outlive men by seven years. During this period, CVD is second only to joint and bone dise'ase in limiting activities and reducing the autonomy of these women.2...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Internal Medicine
سال: 2000
ISSN: 0003-9926
DOI: 10.1001/archinte.160.16.2498